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. NK cells mediate resistance against haematopoietic neoplasms but are generally considered to play a minor role in solid tumour carcinogenesis [5] [6] [7] . Here we report that IL-1R8 serves as a checkpoint for NK cell maturation and effector function. Its genetic blockade unleashes NK-cell-mediated resistance to hepatic carcinogenesis, haematogenous liver and lung metastasis, and cytomegalovirus infection.
Several lines of evidence suggest that IL-1R8 interferes with the association of TIR module-containing adaptor molecules with signalling receptor complexes of the ILR or TLR family, tuning downstream signalling, thus negatively controlling inflammatory and immune responses and T helper cell polarization and functions 1, 8 . Moreover, IL-1R8 is the co-receptor of IL-1R5/IL-18Rα for IL-37, and is required for the anti-inflammatory activity of this human cytokine 9 . Deregulated activation by ILR or TLR ligands in IL-1R8-deficient mice has been associated with exacerbated inflammation and immunopathology, including selected cancers, or autoimmune diseases 10 . IL-1R8 is widely expressed 10 . However, we found strikingly high levels of IL-1R8 mRNA and protein in human NK cells, compared with other circulating leukocytes and monocyte-derived macrophages (Fig. 1a and Extended Data Fig. 1a) . IL1R8 mRNA levels increased during NK cell maturation 11 (Extended Data Fig. 1b ) and surface protein expression mirrored transcript levels (Fig. 1b and Extended Data Fig. 1c ). IL-1R8 expression was detected at a low level in bone marrow pluripotent haematopoietic stem cells and NK cell precursors, and was selectively upregulated in mature NK cells but not in CD3 + lymphocytes (Extended Data Fig. 1d ).
Mouse NK cells expressed significantly higher levels of Il1r8 mRNA compared with other leukocytes (Fig. 1c ) and other ILRs (Extended Data Fig. 1e , f). In line with the results obtained in human NK cells, the Il1r8 mRNA level increased during the four-stage developmental transition from CD11b low CD27 low to CD11b high CD27 low (ref. 12) ( Fig. 1d and Extended Data Fig. 1g ).
To assess the role of IL-1R8 in NK cells, we took advantage of IL-1R8-deficient mice. Among CD45 + cells, the NK cell frequency and absolute numbers were significantly higher in peripheral blood of Il1r8 −/− compared with Il1r8 +/+ mice, and slightly increased in liver and spleen. (Fig. 2a, b ). In addition, the frequency of the CD11b high CD27 low and KLRG1 + mature subsets were significantly higher in Il1r8 −/− mice than Il1r8 +/+ mice in bone marrow, spleen and blood, indicating a more mature phenotype of NK cells 13 (Fig. 2c, d and Extended Data Fig. 2a, b) .
The enhanced NK cell maturation in Il1r8 −/− mice occurred already at 2 and 3 weeks of age, whereas the frequency of NK precursors was similar in Il1r8 −/− and Il1r8 +/+ bone marrow, indicating that IL-1R8 regulated early events in NK cell differentiation, but did not affect the development of NK cell precursors 12 (Extended Data Fig. 2c -e). We next investigated whether IL-1R8 affected NK cell function. The expression of the activating receptors NKG2D, DNAM-1 and Ly49H was significantly upregulated in peripheral blood Il1r8 −/− NK cells (Extended Data Fig. 2f ). Interferon-γ (IFNγ ) and granzyme B production and FasL expression were more sustained in IL-1R8-deficient NK cells upon ex vivo stimulation in the presence of ). The frequency of IFNγ + NK cells was higher in Il1r8 −/− total NK cells and in all NK cell subsets. Thus, IFNγ production was enhanced independently of the NK cell maturation state. Analysis of competitive bone marrow chimaeras revealed that IL-1R8 regulates NK cell differentiation in a cellautonomous way (Extended Data Fig. 2h-k) . Along the same line, co-culture experiments of NK cells with lipopolysaccharide (LPS)-or CpG-primed dendritic cells showed that Il1r8 −/− NK cells produced higher IFNγ levels irrespective of the dendritic cell genotype (Extended Data Fig. 2l ).
IL-18 is a member of the IL-1 family, which plays an important role in NK cell differentiation and function 1, 14 . Enhanced NK cell maturation and effector function in Il1r8 −/− mice was abolished by IL-18 blockade or genetic deficiency but unaffected by IL-1R1-deficiency (Fig. 2h, i and Extended Data Fig. 3a, b) . Co-housing and antibiotic treatment had no impact, thus excluding a role of microbiota 15 in the phenotype of Il1r8 −/− mice (Extended Data Fig. 3c, d ). The results reported above suggested that IL-1R8 regulated the IL-18 signalling pathway in NK cells and, indeed, an increased phospho-IRAK4/IRAK4 ratio was induced by IL-18 in Il1r8 −/− NK cells compared with wild-type NK cells, indicating unleashed early signalling downstream of MyD88 and myddosome formation (Fig. 2j) , consistent with the proposed molecular mode of action of 9, 16) . Indeed, by stimulated emission depletion (STED) microscopy, we observed clustering of IL-1R8 and IL-18Rα (Extended Data Fig. 3e ), in line with previous studies Letter reSeArCH
To obtain a deeper insight into the impact of IL-1R8 deficiency on NK cell function and on the response to IL-18, RNA sequencing (RNAseq) analysis was conducted. IL-1R8 deficiency had a profound impact on the resting transcriptional profile of NK cells and on top on responsiveness to Extended Data Fig. 4a and Supplementary Table 1 ). The profile of IL-1R8-deficient cells includes activation pathways (for example, MAPK), adhesion molecules involved in cell-tocell interactions and cytotoxicity (ICAM-1), and increased production of selected chemokines (CCL4). The last of these may represent an NK-cell-based amplification loop of leukocyte recruitment, including NK cells themselves.
To investigate the role of IL-1R8 in human NK cells (Fig. 1a, b) , we first retrospectively analysed its expression in relation to responsiveness to a combination of IL-18 and IL-12 in normal donors. We observed an inverse correlation between IL-1R8 levels and IFNγ production by peripheral blood NK cells (r 2 = 0.7969, P = 0.0012) (Fig. 2l) . In addition, IL-1R8 partial silencing in peripheral blood NK cells with small interfering RNA (siRNA) was associated with a significant increase in IFNγ production ( Fig. 2m) and upregulation of CD69 expression (not shown). These results suggest that in human NK cells, as in mouse counterparts, IL-1R8 serves as a negative regulator of activation and that its inactivation unleashes human NK-cell effector function.
To assess the actual relevance of IL-1R8-mediated regulation of NK cells, anticancer and anti-viral resistance were examined. The liver is characterized by a high frequency of NK cells
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. Therefore we focused on liver carcinogenesis. In a model of diethylnitrosamine-induced . MFI, mean fluorescence intensity. c, d, Il1r8 mRNA expression in mouse primary NK cells and other leukocytes (c) and in sorted splenic NK cell subsets (d). * P < 0.05, * * P < 0.01, * * * P < 0.001, one-way analysis of variance (ANOVA). Mean ± s.e.m. were protected against the development of lesions, in terms of macroscopic number, size ( Fig. 3a and Extended Data Fig. 5a , b) and histology (data not shown). The percentage and absolute number of NK cells, and the percentage of IFNγ + NK cells, were higher in Il1r8 −/− hepatocellular carcinoma-bearing mice (Fig. 3b, c and Extended Data Fig. 5c ). Finally, increased levels of cytokines involved in anti-tumour immunity (for example, IFNγ ) and a reduction of pro-inflammatory cytokines associated with tumour promotion (IL-6, TNF , IL-1β , CCL2, CXCL1) were observed (Extended Data Table 1 ). Most importantly, the depletion of NK cells abolished the protection against liver carcinogenesis observed in Il1r8 −/− mice ( Fig. 3d and Extended Data Fig. 5d ). Evidence suggests that NK cells can inhibit haematogenous cancer metastasis 5 . In a model of sarcoma (MN/MCA1) spontaneous lung metastasis, Il1r8 −/− mice showed a reduced number of haematogenous metastases, whereas primary tumour growth was unaffected ( Fig. 3e and Extended Data Fig. 5e, f) . The frequency of total and mature CD27 low NK cells was higher in Il1r8 −/− lungs ( Fig. 3f and data not shown). Assessment of lung metastasis at the time of euthanasia and in vivo imaging analysis ( Fig. 3g and Extended Data Fig. 5e ) showed that the protection was completely abolished in NK-cell-depleted Il1r8 −/− mice. In addition, IL-18 or IFNγ neutralization abolished or markedly reduced the protection against metastasis observed in Il1r8 −/− mice (Extended Data Fig. 5g ). In contrast, depletion of CD4 + /CD8 + cells or IL-17A, or deficiency of IL-1R1 (involved in T helper 17 cell development), did not affect the phenotype (Extended Data Fig. 5h, i) .
Liver metastasis is a major problem in the progression of colorectal cancer. We therefore assessed the potential of Il1r8 −/− NK cells to protect against liver metastasis using the MC38 colon carcinoma line 21 . As shown in Fig. 3h , Il1r8 −/− mice were protected against MC38 colon carcinoma liver metastasis. In addition, IL-18 genetic deficiency abrogated the protection against liver metastasis observed in Il1r8 −/− mice (Extended Data Fig. 5j ), thus indicating that the IL-1R8-dependent control of MC38-derived liver metastasis occurs through the IL-18/ IL-18R axis. To assess the primary role of Il1r8 −/− NK cells in the cancer protection, adoptive transfer was used (Extended Data Fig. 5k-m) . Adoptive transfer of Il1r8 +/+ NK cells had no effect on lung and liver metastasis. In contrast, adoptive transfer of Il1r8 −/− NK cells significantly and markedly reduced the number and volume of lung and liver metastases (Fig. 3i, j and Extended Data Fig. 5n ). Given the natural history and clinical challenges of colorectal cancer, this observation has potential translational implications. Thus, IL-1R8 genetic inactivation unleashes NK-cell-mediated resistance to carcinogenesis in the liver and amplifies the anti-metastatic potential of these cells in liver and lung in a NK-cell-autonomous manner.
Finally, we investigated whether IL-1R8 affects NK cell anti-viral activity, focusing on murine cytomegalovirus (MCMV) infection 22 . As shown in Fig. 4a , liver viral titres were lower in Il1r8 −/− than Il1r8
mice, indicating that IL-1R8-deficiency was associated with a more efficient control of MCMV infection. The frequency of IFNγ + NK cells and degranulation (that is, the frequency of CD107a + NK cells) were significantly higher in the spleen and liver of Il1r8 −/− mice on day 1.5 after infection (Fig. 4b) . On day 4.5 after infection, IFNγ + and CD107a + NK cells were strongly reduced, in both spleen and liver, as a consequence of better control of viral spread (Fig. 4b ). Consistent with a more efficient control of the infection, reduced levels of proinflammatory cytokines were observed in Il1r8 −/− mice (Extended Data Fig. 6a ). NK-cell adoptive transfer experiments were performed in MCMV-infected newborn mice that still did not have mature NK cells 12 . As shown in Fig. 4c , the adoptive transfer of Il1r8 −/− NK cells conferred higher protection than Il1r8 +/+ NK cells, with, for instance, four out of nine mice having no detectable virus titre in the brain.
NK cells belong to the complex, diverse realm of innate lymphoid cells (ILCs) 23 . Human and mouse non-NK ILCs express IL-1R8 mRNA and protein (ref. 24, our unpublished data and C. Jandus, personal communication) . Preliminary experiments were conducted to assess the role of IL-1R8 in ILC function. In the MCMV infection model, Il1r8 −/− ILC1 showed increased IFNγ production, but represented a minor population compared with NK cells and one-thirtieth that of Il1r8 −/− IFNγ -producing cells (Fig. 4d) ; they are therefore unlikely to play a significant role in the phenotype. These results provide initial evidence that IL-1R8 has a regulatory function in ILCs. Further studies are required to assess its actual relevance in ILC diverse populations. Collectively, these results indicate that IL-1R8-deficient mice were protected against MCMV infection and that protection was dependent on increased NK cell activation.
IL-1R8 deficiency was associated with exacerbated inflammatory and immune reactions under a variety of conditions 1, 10 . NK cells engage in bidirectional interactions with macrophages, dendritic cells and other lymphocytes 3, 4, 25, 26 . Therefore the role of NK cells in inflammatory and autoimmune conditions associated with IL-1R8 deficiency 1,10 will need to be examined. IL-1R8-deficient mice show increased susceptibility to colitis and colitis-associated azoxymethane carcinogenesis 27, 28 . The divergent impact on carcinogenesis of IL-1R8 deficiency in the intestine and liver is likely to reflect fundamental, tissue-dictated differences of immune mechanisms involved in carcinogenesis in these different anatomical sites. In particular, high numbers of NK cells are present in the liver 19 and this physiological characteristic of this organ is likely to underlie this apparent divergence.
NK cells are generally not credited with playing a major role in the control of solid tumours 6 . Conversely there is evidence for a role of NK cells in the control of haematogenous lung metastasis 5, 29 . The results presented here show that unleashing NK cells by genetic inactivation of IL-1R8 resulted in inhibition of liver carcinogenesis and protection against liver and lung metastasis. IL-1R8-deficient mice show exacerbated TLR and IL-1-driven inflammation 10 , and inflammation promotes liver carcinogenesis 30 . Therefore, our results are probably an underestimate of the potential of removal of the NK cell checkpoint IL-1R8 against liver primary and metastatic tumours. Thus, NK cells have the potential to restrain solid cancer and metastasis, provided critical, validated checkpoints such as IL-1R8 are removed and the tissue immunological landscape is taken into account.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 461-475 (2007 All efforts were made to minimize the number of animals used and their suffering. In most in vivo experiments, the investigators were unaware of the genotype of the experimental groups. Human primary cells. Human peripheral mononuclear cells were isolated from peripheral blood of healthy donors, upon approval by the Humanitas Research Hospital Ethical Committee. Peripheral mononuclear cells were obtained through a Ficoll density gradient centrifugation (GE Healthcare Biosciences). NK cells were then purified by a negative selection, using a magnetic cell sorting technique according to the protocols given by the manufacturer (EasySep Human NK Cell Enrichment Kit, Stem Cell Technology). Human monocytes were obtained from peripheral blood of healthy donors by two-step gradient centrifugation, first by Ficoll and then by Percoll (65% iso-osmotic; Pharmacia, Uppsala, Sweden). Residual T and B cells were removed from the monocyte fraction by plastic adherence. Monocytes were cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS), 1% l-glutamine, 1% penicillin/streptomycin and 100 ng ml −1 M-CSF (Peprotech) for 7 days to generate resting macrophages. T and B cells were obtained from peripheral blood of healthy donors using RosetteSep Human T Cell Enrichment Cocktail and RosetteSep Human B Cell Enrichment Cocktail (Stem Cell Technology), following the manufacturer's instructions. Neutrophils were enriched from Ficoll-isolated granulocytes, using an EasySep Human Neutrophil Enrichment Kit (StemCell Technologies), according to the manufacturer's instructions.
To analyse pluripotent haematopoietic stem cells and NK cell precursors, human bone marrow mononuclear cells were collected from Humanitas Biobank, upon approval by the Humanitas Research Hospital Ethical Committee (authorization 1516, issued on 26 February 2016). Frozen samples were thawed and vitality was assessed by trypan blue and Aqua LIVE/Dead-405 nm staining (Invitrogen), before flow cytometry analysis.
Informed consent was obtained from all participants. Fluorescence-activated cell sorting (FACS) analysis. Single-cell suspensions of bone marrow, blood, spleen, lung and liver were obtained and stained. A representative NK cell gating strategy is reported in Supplementary Fig. 1 . A Foxp3/ Transcription Factor Staining Buffer Set (eBioscience) was used for intracellular staining of granzyme B and perforin. Cytofix/Cytoperm (BD Biosciences) was used for intracellular staining of IFNγ . Liver ILC1 were identified as NK1.1 + CD3 − CD49a + CD49b − cells. Formalin 4% and methanol 100% were used for intracellular staining of IRAK4, pIRAK4, pS6 and JNK. The following mouse antibodies were used: CD45-BV605, -BV650 or -PerCp-Cy5.5 (clone 30-F11); CD45.1-BV650 (clone A20); CD45.2-APC, -BV421 (clone 104); CD3e-PerCP-Cy5.5 or -APC (clone 145-2C11); CD19-PerCP-Cy5.5, -eFluor450 (clone 1D3); NK1.1-PE, -APC, -eFluor450 or -Biotin (clone PK136); CD11b-BV421, -BV450, -BV785 (clone M1/70); CD27-FITC or -APC-eFluor780 (clone LG.7F9); CD4-FITC (clone RM 4-5); CD8-PE (clone 53-6.7); KLRG-1-BV421 (clone 2F1); NKG2D-APC (clone CX5); DNAM-1-APC (clone 10E5); Ly49H-PECF594 (clone 3D10); Granzyme B-PE (clone NGZB); Perforin-PE (clone eBioOMAK-D); IFNγ -Alexa700 or -APC (clone XMG1.2); CD107a-Alexa647 (clone 1D4B); FasL-APC (clone MFL3); Lineage Cell Detection Cocktail-Biotin; Sca-1-FITC (clone D7); CD117-PE or -Biotin (clone 3C11); CD127-eFluor450 (clone A7R34); CD135-APC or -Biotin (clone A2F10.1); CD244-PE (clone 2B4); CD122-PE-CF594 (clone TM-Beta1); CD49b-PE-Cy7 or Biotin (clone DX5), CD49a-APC (clone Ha31/8), from BD Bioscience, eBioscience, BioLegend or Miltenyi Biotec. The following human antibodies were used: CD56-PE (clone CMSSB); CD3-FITC (clone UCHT1); CD16-Pacific Blue (clone 3G8); CD34-PE-Vio770 (clone AC136); CD117-BV605 (clone 104D2); NKp46-BV786 (clone 9E2/NKp46); CD45-PerCP (clone 2D1); CD19-APC-H7 (clone SJ25C1); CD14-APC-H7 (clone M5E2); CD66b-APC-Vio770 (clone REA306), from BD Bioscience, eBioscience or Miltenyi Biotec. Biotinylated anti-hSIGIRR (R&D Systems) and streptavidin Alexa Fluor 647 (Invitrogen) were used to stain IL-1R8 in human cells. Human NKT cells were detected using PE-CD1d tetramers loaded with α GalCer (ProImmune, Oxford, UK). Antibodies to detect protein phosphorylation were as follows: p-IRAK4 Thr345/Ser346 (clone D6D7), IRAK4, p-S6-Alexa647 Ser235/236 (clone D57.2.2E); p-SAPK/JNK Thr183/Tyr185 (clone 81E11), from Cell Signaling Technology. A goat anti-rabbit Alexa Fluor 647 secondary antibody (Invitrogen) was used to stain p-IRAK4, IRAK4 and p-SAPK/JNK. Results are reported as mean fluorescence intensity normalized on isotype control or fluorescence minus one. Cell viability was determined by Aqua LIVE/Dead-405 nm staining (Invitrogen) or Fixable Viability Dye (FVD) eFluor 780 (eBioscience); negative cells were considered viable. Cells were analysed on an LSR Fortessa or FACSVerse (BD Bioscience). Data were analysed with FlowJo software (Treestar). Quantitative PCR. Total RNA was extracted using Trizol reagent (Invitrogen) following the manufacturer's recommendations. RNA was further purified using an miRNeasy RNA isolation kit (Qiagen) or Direct-zol RNA MiniPrep Plus (Zymo Research). cDNA was synthesized by reverse transcription using a High Capacity cDNA Archive Kit (Applied Biosystems) and quantitative real-time PCR was performed using SybrGreen PCR Master Mix (Applied Biosystems) in a CFX96 Touch Real-Time PCR Detection System (Bio-Rad). PCR reactions were performed with 10 ng of DNA. Data were analysed with the 2 (−ΔCT) method. Data were normalized on the basis of GAPDH, β -actin or 18S expression, as indicated, determined in the same sample. Analysis of all samples was performed in duplicate. Primers were designed according to the published sequences and listed as follows: s18/S18: forward 5′ -ACT TTC GAT GGT AGT CGC CGT-3′ , reverse 5′ -CCT TGG ATG TGG TAG CCG TTT-3′ ; Gapdh/GAPDH: forward 5′ -GCA AAG TGG AGA TTG TTG CCA T-3′ , reverse 5′ -CCT TGA CTG TGC CGT TGA ATT T-3′ ; Actb/ ACTB: forward 5′ -CCC AAG GCC AAC CGC GAG AAG AT-3′ , reverse 5′ -GTC CCG GCC AGC CAG GTC CAG-3′ ; Il1r8: forward 5′ -AGA GGT CCC AGA AGA GCC AT-3′ , reverse 5′ -AAG CAA CTT CTC TGC CAA GG-3′ ; IL1R8: forward 5′ -ATG TCA AGT GCC GTC TCA ACG-3′ , reverse 5′ -GCT GCG GCT TTA GGA TGA AGT-3′ ; Il1r1: forward 5′ -TGC TGT CGC TGG AGA TTG AC-3′ , reverse 5′ -TGG AGT AAG AGG ACA CTT GCG AA-3′ ; Il1r2: forward 5′ -AGT GTG CCC TGA CCT GAA AGA-3′ , reverse 5′ -TCC AAG AGT ATG GCG CCC T-3′ ; Il1r3: forward 5′ -GGC TGG CCC GAT AAG GAT-3′ , reverse 5′ -GTC CCC AGT CAT CAC AGC G-3′ ; Il1r4: forward 5′ -GAA TGG GAC TTT GGG CTT TG-3′ , reverse 5′ -GAC CCC AGG ACG ATT TAC TGC-3′ ; Il1r5: forward 5′ -GCT CGC CCA GAG TCA CTT TT-3′ , reverse 5′ -GCG ACG ATC ATT TCC GAC TT-3′ ; Il1r6: forward 5′ -GCT TTT CGT GGC AGC AGA TAC-3′ , reverse 5′ -CAG ATT TAC TGC CCC GTT TGT T-3′ ; 16S: forward 5′ -AGA GTT TGA TCC TGG CTC AG-3′ , reverse 5′ -GGC TGC TGG CAC GTA GTT AG-3′ . Purification of mouse leukocytes. Splenic NK cells and bone marrow neutrophils were enriched by MACS according to the manufacturer's instructions (Miltenyi Biotec). Purity of NK cells was about 90% as determined by FACS. The purity of neutrophils was ≥ 97.5%. NK cells were stained (CD45-BV650, NK1.1-PE, CD3e-APC, CD11b-BV421, CD27-FITC) and sorted on a FACSAria cell sorter (BD Bioscience) to obtain high-purity NK cells and NK cell populations (CD11b low CD27 ). Splenic B and T lymphocytes were stained (CD45-PerCP, CD3e-APC, CD4-FITC, CD8-PE, CD19-eFluor450) and sorted. The purity of each population was ≥ 98%. Resulting cells were processed for mRNA extraction or used for adoptive transfer or co-culture experiments. In vitro-derived macrophages were obtained from bone marrow total cells. Bone marrow cells were cultured in RPMI-1640 medium supplemented with 10% FBS, 1% l-glutamine, 1% penicillin/ streptomycin and 100 ng ml −1 M-CSF (Peprotech) for 7 days to generate resting macrophages. Bone marrow cells were cultured in RPMI-1640 medium supplemented with 10% FBS, 1% l-glutamine, 1% penicillin/streptomycin and 20 ng ml −1 GM-CSF (Peprotech) for 7 days to generate dendritic cells. Confocal microscopy. Mouse splenic NK cells were enriched by magnetic cell sorting, left to adhere on poly-d-lysine (Sigma-Aldrich) coated coverslips, fixed with 4% PFA, permeabilized with 0.1% Triton X-100 and incubated with blocking buffer (5% normal donkey serum (Sigma-Aldrich), 2% BSA, 0.05% Tween). Cells were then stained with biotin-conjugated goat polyclonal anti-SIGIRR antibody or biotin-conjugated normal goat IgG as control (both R&D Systems) (10 μ g ml ) followed by Alexa Fluor 488-conjugated donkey anti-goat IgG antibody (Molecular Probes) and 4′ ,6-diamidino-2-phenylindole (DAPI) (Invitrogen). Coverslips were mounted with the antifade medium FluorPreserve Reagent (EMD Millipore) and analysed with an Olympus Fluoview FV1000 laser scanning confocal microscope with a 40× oil immersion lens (numerical aperture 1.3). STED microscopy. Human NK cells were enriched and left to adhere on polyd-lysine (Sigma-Aldrich) -coated coverslips, stimulated with IL-18 (50 ng ml −1 ; 1 min, 5 min, 10 min), fixed with 4% PFA, incubated with 5% normal donkey serum Letter reSeArCH (Sigma-Aldrich), 2% BSA, 0.05% Tween in PBS2+ (pH 7.4) (blocking buffer), and then with biotin-conjugated goat polyclonal anti-human IL-1R8 antibody or biotin-conjugated normal goat IgG (all from R&D Systems) and mouse monoclonal anti-IL-18Rα (Clone 70625; R&D Systems) or mouse IgG1 (Invitrogen), all diluted at 5 μ g ml −1 in blocking buffer, followed by Alexa Fluor 488-conjugated donkey anti-goat IgG antibody and Alexa Fluor 555 donkey anti-mouse IgG antibody (both from Molecular Probes). Mowiol was used as mounting medium. STED xyz images were acquired in a unidirectional mode with a Leica SP8 STED3X confocal microscope system. Alexa Fluor 488 was excited with a 488 nm argon laser and emission collected from 505 to 550 nm applying a gating between 0.4 and 7 ns to avoid collection of reflection and autofluorescence. Alexa Fluor 555 was excited with a 555/547 nm-tuned white light laser and emission collected from 580 to 620 nm. Line sequential acquisition was applied to avoid fluorescence overlap. The 660 nm CW-depletion laser (80% of power) was used for both excitations. Images were acquired with Leica HC PL APO 100× /1.40 numerical aperture oil STED White objective at 572.3 milli absorption unit (mAU). CW-STED and gated CW-STED were applied to Alexa Fluor 488 and Alexa Fluor 555, respectively. Collected images were de-convolved with Huygens Professional software. 3′-mRNA sequencing and analysis. Splenic NK cells (from six mice per genotype and pooled in pairs) were purified as described above and stimulated with IL-18 (MBL) (20 ng ml −1 for 4 h). RNA was prepared as described above. A QuantSeq 3′ mRNA-seq Library Prep Kit for Illumina (Lexogen) was used to generate libraries, which were sequenced on the NextSeq (Illumina; 75 bp PE). The fastq sequence files were assessed using the fastqc program. The reads were first trimmed using bbduk in the bbmap suite of software 32 to remove the first 12 bases and a contaminant kmer discovery length of 13 was used for contaminant removal. Regions of length 20 or above with average quality of less than 10 were trimmed from the end of the read. The reads were then trimmed to remove trailing polyG and polyA runs using cutadapt 33 and the quality of the remaining reads reassessed with fastqc. The trimmed reads were aligned to the mm10 genomic reference and reads assigned to features in the mm10 annotation using the STAR program 34 . Differential expression analysis used the generalized linear model functions in the R/bioconductor 35 edgeR package 36 with TMM normalization. Gene set analysis used the romer 37 function in the R/bioconductor package limma 38 . Metascape (http://metascape.org) was used to enrich genes for Gene Ontology biological processes, KEGG Pathway and Reactome Gene Sets. Measurement of cytokines. A BD Cytometric Bead Array (CBA) mouse inflammation kit (BD) or Duoset ELISA kits (R&D Systems) were used to measure cytokines. In vitro functional assays. Total mouse splenocytes or enriched mouse or human NK cells were cultured in RPMI-1640 medium supplemented with 10% FBS 1% l-glutamine, 1% penicillin/streptomycin and treated with IL-2, IL-12, IL-15 (Peprotech), IL-18 (MBL), IL-1β (Peprotech) and PMA-Ionomycin (SigmaAldrich), as specified. FasL expression was evaluated upon treatment for 45 min with IL-18 (50 ng ml ) were added 4 h before intracellular staining, when specified.
NK-dendritic-cell co-culture experiments were performed as previously described 39 . Dendritic cells were treated with LPS from Escherichia coli O55:B5 (Sigma-Aldrich; 1 μ g ml ) and with anti-mIL-18 neutralizing antibody (BioXCell, Clone YIGIF74-1G7; 5 μ g ml ) or Rat Isotype Control (BioXCell, Clone 2A3).
IFNγ and CD107a expression upon viral infection was analysed by flow cytometry upon 4 h treatment with BD GolgiPlug, BD GolgiStop and IL-2 (500 U ml ). Human primary NK cell transfection. Human NK cells were enriched from peripheral blood of healthy donors and transfected with Dharmacon Acell siRNA (GE Healthcare) using Accell delivery medium (GE Healthcare), following the manufacturer's instructions. SIGIRR-specific siRNA (1 μ M) (On-Target Plus; Dharmacon, GE Healthcare) comprised 250 nM of the four following antisense sequences: I, AGU UUC GCG AGC CGA GAU CUU; II, UAC CAG AGC AGC ACG UUG AUU; III, UGA CCC AGG AGU ACU CGU GUU; IV, CUU CCC GUC GUU UAU CUC CUU (all 5′ to 3′ ).
Generation of bone marrow chimaeras. Il1r8
−/− and Il1r8 +/+ mice were lethally irradiated with a total dose of 900 cGy. Two hours later, mice were injected in the retro-orbital plexus with 4 × 10 6 nucleated bone marrow cells obtained by flushing of the cavity of freshly dissected femurs from wild-type or Il1r8 −/− donors. Competitive bone marrow chimaeric mice were generated by reconstituting recipient mice with 50% CD45.1 Il1r8 +/+ and 50% CD45.2 Il1r8 −/− bone marrow cells. Recipient mice received gentamycin (0.8 mg ml −1 in drinking water) starting 10 days before irradiation and for 2 weeks after irradiation. NK cells of chimaeric mice were analysed 8 weeks after bone marrow transplantation. Depletion and blocking experiments. Mice were treated intraperitoneally with 200 μ g of specific mAbs (mouse anti-NK1.1, clone PK136; mouse isotype Control, clone C1.18.4; rat anti-mIL-18, clone YIGIF74-1G7; rat isotype Control, clone 2A3; rat anti-IFNγ , clone XMG1.2; rat IgG1 HRPN; mouse anti-IL-17A, clone 17F3; mouse isotype Control, clone MOPC-21; rat anti-CD4/CD8, clone GK1.5/YTS; rat isotype Control, clone LTF-2 (all from BioXCell)) and then with 100 μ g once (anti-NK1.1) or three times (anti-IL-18, anti-IFNγ , anti-IL-17A, anti-CD4/CD8) a week for the entire duration of the experiment. Microflora depletion. Six-week-old mice were treated every day for 5 weeks by oral gavage with a cocktail of antibiotics (ampicillin (Pfizer) 10 mg ml ). Control mice were treated with drinking water. A gavage volume of 10 ml/kg (body weight) was delivered with a stainless-steel tube without prior sedation of mice. DNA was isolated from bacterial faecal pellets with a PowerSoil DNA Isolation Kit (MO BIO Laboratories) and quantified by spectrophotometry at 260 nm. PCR was performed with 10 ng of DNA using SybrGreen PCR Master Mix (Applied Biosystems) in a CFX96 Touch Real-Time PCR Detection System (Bio-Rad). Data were analysed with the 2 (−ΔCT) method (Applied Biosystems, Real-Time PCR Applications Guide). Cancer models. Mice were injected intraperitoneally with 25 mg/kg (body weight) of diethylnitrosamine (Sigma) at 15 days of age. They were euthanized 6, 8, 10 or 12 months later, to analyse liver cancer. Liver cancer score was based on the number and volume of lesions (0: no lesions; 1: lesion number < 3, or lesion dimension < 3 mm; 2: lesion number < 5, or lesion dimension < 5 mm; 3: lesion number < 10, or lesion dimension < 10 mm; 4: lesion number < 15, or lesion dimension < 10 mm; 5: lesion number > 15, or lesion dimension > 10 mm). Lung metastasis experiments were performed injecting intramuscularly the 3-MCA-derived mycoplasma-free sarcoma cell line MN/MCA1 (10 5 cells per mouse in 100 μ l PBS) 40 . Primary tumour growth was monitored twice a week, and lung metastases were assessed by in vivo imaging and by macroscopic counting at the time of being euthanized 25 days after injection. Liver metastases were generated by injecting intrasplenically 1.5 × 10 5 mycoplasma-free colon carcinoma cells (MC38) 21 . Mice were euthanized 12 days after injection and liver metastases were counted macroscopically. MC38 cells were received from ATCC just before use. MN/MCA1 cells were authenticated morphologically by microscopy in vitro and by histology ex vivo. Tumour size limit at which mice were euthanized was based on major diameter (not more than 2 cm). Viral infections. Mice were injected intravenously with 5 × 10 5 plaque-forming units of the tissue-culture-grown virus in PBS. Bacterial artificial chromosomederived MCMV strain MW97.01 has been previously shown to be biologically equivalent to MCMV strain Smith (VR-1399) and is hereafter referred to as wildtype MCMV 41 . Mice were euthanized 1.5 and 4.5 days after infection and viral titre was assessed by plaque assay, as previously described 42, 43 . Newborn mice were infected intraperitoneally with 2,000 plaque-forming units of the MCMV strain MW97.01 and euthanized at day 7 after infection. Viral titre was assessed by plaque assay, as previously described 42, 43 .
Adoptive transfer. One million Il1r8
+/+ or Il1r8 −/− sorted NK cells were injected intravenously in wild-type adult mice 5 h before MN/MCA or MC38 injection, or intraperitoneally in newborn mice 48 h after MCMV injection. Adoptively transferred NK cell engraftment, proliferative capacity and functionality (IFNγ production and degranulation after ex vivo stimulation) were assessed 3 and 7 days after injection. In vivo proliferation. In vivo proliferation was measured using a Click-iT Edu Flow Cytometry Assay Kit (Invitrogen). Edu was injected intraperitoneally (0.5 mg per mouse), mice were euthanized 24 h later and cells were stained following the manufacturer's instructions and analysed by flow cytometry. Immunohistochemistry. Frozen liver tissues were cut at 8 mm and then fixed with 4% PFA. Endogenous peroxidases were blocked with 0.03% H 2 O 2 for 5 min and unspecific binding sites were blocked with PBS + 1% FBS for 1 h. Tissues were stained with polyclonal goat anti-mouse NKp46/NCR1 (R&D Systems) and a Goaton-Rodent HRP polymer kit (GHP516, Biocare Medical) was used as secondary antibody. Reactions were developed with 3,3′ -diaminobenzidine (Biocare Medical) and then slides were counterstained with haematoxylin. Slides were mounted with eukitt (Sigma-Aldrich). Images at 20× magnification were analysed with cell^F software (Olympus).
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In vivo imaging. After feeding with AIN-76A alfalfa-free diet (Mucedola, Italy) for 2 weeks to reduce fluorescence background, mice were intravenously injected with XenoLight RediJect 2-deoxyglucosone (PerkinElmer) and 24 h later 2-deoxyglucosone fluorescence was measured using a Fluorescence Molecular Tomography system (FMT 2000, Perkin Elmer) . Acquired images were subsequently analysed with TrueQuant 3.1 analysis software (Perkin Elmer). Data availability. The data discussed in this publication have been deposited in the NCBI Gene Expression Omnibus (GEO) under accession number GSE105043, or from the corresponding author. Source Data for Figs 3, 4 and Extended Data Fig. 5 are provided. Statistical analysis. For animal studies, sample size was defined on the basis of past experience on cancer and infection models, to detect differences of 20% or greater between the groups (10% significance level and 80% power). Values were expressed as mean ± s.e.m. or median of biological replicates, as specified. Oneway ANOVA or a Kruskal-Wallis test were used to compare multiple groups. A two-sided unpaired Student's t-test was used to compare unmatched groups with Gaussian distribution and Welch's correction was applied in cases of significantly different variance. A Mann-Whitney U-test was used in cases of non-Gaussian distribution. A ROUT test was applied to exclude outliers. P ≤ 0.05 was considered significant. Statistics were calculated with GraphPad Prism version 6, GraphPad Software. Statistics and reproducibility. Figure 1a Representative experiments out of three (Fig. 2a, b) , five (Fig. 2c) , two (Fig. 2d, j) , four (Fig. 2e) performed. Fig. 2f -m, one experiment performed. Figure 3a , n = 8, 10, 11, 13, 14 mice; Fig. 3b , c, n = 6 mice; Fig. 3d , n = 10, 12, 13 mice; Fig. 3e , n = 10, 11 mice; Fig. 3f , n = 5, 6, 7 mice; Fig. 3g , n = 9, 10 mice; Fig. 3h , n = 5, 6 mice; Fig. 3i, n = 9, 10 or 12 mice; Fig. 3j , n = 6 mice. Representative experiments out of 6 (Fig. 3e), 3 (Fig. 3a) , 2 (Fig. 3d, f, g, h, i) . Fig. 3b , c, j, one experiment performed. Figure 4a , b, n = 5 mice; Fig. 4c , n = 6, n = 9 mice; Fig. 4d , n = 4 mice. Fig. 4a , two experiments were performed. Fig. 4b-d For animal studies, sample size was defined on the basis of past experience on cancer and infection models, in order to detect differences of 20% or grater between the groups (10% significance level and 80% power).
Data exclusions
Describe any data exclusions.
ROUT test was applied to exclude outliers.
Replication
Describe whether the experimental findings were reliably reproduced.
Most experiments were replicated several times with reproducible results as indicated in figure legend/Statistics and reproducibility.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Mice were randomized based on sex, age and weight.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
In most in vivo experiments, the investigators were unaware of the genotype of the experimental groups.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.) A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
